Evidence map›Paper›PMID 41262152›Full record

ArticleJournal of inflammation research2025

Time-Dependent Mortality Predictors in Primary Sjögren's Syndrome: C-Reactive Protein for Early Risk and Age for Late Outcomes.

Jia-Qi Chen, Yan Zhang, Zi-Wei Huang, Jian-Ying Yang, Jia-He Liao, Chun-Xin Lei, Xi-Ya Zhang, Xin-Bo Yu, Tzu-Hua Wu, Zi-Han Liu and 6 more

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jia-Qi ChenGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Yan ZhangGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Zi-Wei HuangGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Jian-Ying YangGraduate School, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.ORCID 0000-0002-3009-8702
Jia-He LiaoGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Chun-Xin LeiGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xi-Ya ZhangGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xin-Bo YuGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.ORCID 0000-0003-2366-5147
Tzu-Hua WuGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Zi-Han LiuGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Bo-Jie TangGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xuan-Yi ZhouGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Tian-Tian DengGraduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Jing Luo *Traditional Chinese Medicine Department of Rheumatism, China-Japan Friendship Hospital, Beijing, People's Republic of China.ORCID 0000-0002-2454-2168
Wei-Jiang SongTraditional Chinese Medicine Department, Peking University Third Hospital, Beijing, People's Republic of China.
Qing-Wen Tao *Traditional Chinese Medicine Department of Rheumatism, China-Japan Friendship Hospital, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To identify risk factors for near-term and long-term death in patients with primary Sjogren's syndrome (pSS). Patients and Methods: This ambispective cohort study included all patients with pSS treated at China-Japan Friendship Hospital between 2013 and 2023. The time-dependent Cox regression analysis was used for statistical analysis of risk factors, with 3 months and 60 months as the cut-off time points and all-cause death as the primary endpoint. Results: Among the 1252 included patients, 138 patients had died by the end of follow-up (11.0%). Age at diagnosis, C-reactive protein (CRP) levels and total bilirubin (TBIL) were time-dependent risk factors for mortality. Within 3 months of follow-up, age > 65 years had no effect on mortality, but after 3 months of follow-up, the mortality risk in patients aged > 65 years increased over time (HR 3.97, 95% CI 2.57-6.13; HR 16.63, 95% CI 5.53-50.03). CRP >6.5 mg/L increased the risk of mortality within 3 months (HR=11.45, 95% CI 2.52-51.95), followed by 3-60 months (HR=2.94, 95% CI 1.94-4.45), but did not affect survival after 60 months of follow-up. TBIL >18.01 µmol/L increased the risk of mortality in pSS patients within 3-6 months (HR=2.30, 95% CI 1.42-3.79) but did not increase the risk of mortality in patients with pSS within 3 months of follow-up or after 60 months. Conclusion: pSS patients with a CRP level >6.5 mg/L have an 11-fold increased risk of near-term death, whereas pSS patients older than 65 years of age at diagnosis have a 16-fold increased risk of long-term death.

Indexed as

inflammationmortalityrisk factorssjögren’s syndrome

Identifiers

PMID41262152
PMCPMC12626160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.